The AT specific minor grove DNA binding ligands bisbenzimidazole derivatives like hoechst-33342 and hoechst-33258 which scavenge free radicals and stabilize macromolecular structure have been shown to afford radioprotection by reducing the induction of DNA damage. However, their ability to inhibit topoisomerases I & II, which play important roles in damage response pathways including DNA repair can enhance radiation damage under certain conditions. Since pool sizes of the topoisomerases differ not only between normal and tumor cells, but also among different tumors, it is anticipated that radiosensitization by hoechst-33342 can vary among tumors. The present studies were, therefore, undertaken to verify this proposition in human glioma (BMG-1 & U-87) and squamous carcinoma (4197 & 4451) cell lines which differ in their biological behavior (ploidy, p53, cyclins, bcl, bax etc).
INTRODUCTION
tumor regression. Since the mechanisms of cyto toxicity differ among these agents, although most Radiation therapy either alone or in combination act through the induction of DNA lesions, an in with surgery is employed in treating majority of sight in to the interactions between these chemo the human tumors. However, its success is limtherapeutic drugs and radiation is expected to ited by inherent resistance of certain tumors, greatly facilitate the development of more potent presence hypoxic cells and heterogeneous popuradiosensitizers for improving cancer therapy. lation with varying degrees of radio-sensitivity,
The radiation response of mammalian cell is char besides limited tolerance of normal tissues.
acterized by induction and repair of DNA damTherefore, development of approaches and age, cell cycle progression, alteration in signal agents, which selectively sensitize tumors contransduction and apoptosis. Since DNA damage, tinue to be a major focus of research in experiinfluences of all these processes, induction and mental radiation oncology. Towards this end, comrepair of DNA damage are considered the most bined modality employing different variety of important determinants of radiation response chemotherapeutic agents and ionizing radiation influencing cell death, mutation and transforma is one of the widely used strategy with enhanced tion. [5, 6, 7] Both these processes are influenced by therapeutic efficacy, particularly in the form of a number of physico-chemical and biological fac local tumor control as compared to either of the tors that include the nature and dose of radia modality when used alone. [1, 2] In addition to their tion, oxygen tension, levels of free radical scav inherent cytotoxicity, certain chemotherapeutic engers, pool sizes of the repair enzyme and drugs have been found to enhance radiation-innucleotides, cell cycle position and the status of duced cell death i.e radiosensitization, [3, 4] which chromatin organization, [8, 9, 10, 11] While damage in could be partly responsible for the improved duction by low LET radiation is significantly higher in DNA associated with relatively more open chro matin structure, [12] several events in the repair like damage recognition and recruitment of repair elements are greatly influenced by the chromatin status. Although acetylation of histones has been shown to profoundly influence the degree of chromatin condensation, topological modifications of DNA, regulated by topoisomerases also play an impor tant role in maintaining the optimal status during several DNA transactions like replication, transcription and repair. [13] Topoisomerases are a class of nuclear enzymes involved in DNA winding and unwinding thereby facilitating the pro gression of replication fork, [14, 15] transcriptional bubble and separation of daughter strands (chromosome segregation) during mitosis. [16] Topoisomerase II (TOP II) is an integral component of nuclear matrix and an important regulator of DNA synthesis, [17] chromosome condensation and separa tion. [18] On the other hand, topoisomerase I (TOP I) is be lieved to facilitate chromatin assembly, recombination, cell division, template reading by RNA polymerase. [14, 18] The en zymes (TOP I and TOP II) first bind to DNA in a non-covalent manner, followed by nicking of one or two strands during which the enzyme and DNA become covalently linked. [18] This hybrid an intermediate in the topological manipula tion of DNA by the enzyme is called cleavable complex. [19] After rewinding of the helix, the strands are re-ligated. Many compounds that specifically stabilize the cleavable complex by interfering in the religation process have shown strong anti-proliferative and apoptotic effects and thereby cur rently employed as anticancer drugs. [20, 21, 22] The bisbenzimidazole derivatives hoechst (hoechst-33258 and hoechst-33342) are AT rich, minor grove-binding ligands that protect DNA against low LET ionizing radiation dam age primarily due to its ability to scavenge free radicals and quench DNA radicals, [23, 24, 25] although a stabilization of macro molecular structure and displacement of DNA bound water molecules have also been suggested. [26, 27] However, the DNA bound ligand has also been shown to alter the chromatin condensation [28] and therefore interfere in the repair of DNA damage. [29, 30] Furthermore, the ligand has been shown to inhibit the functioning topoisomerases stabilizing the cleav able complexes, thereby leading to cell death.
[18] Induction of protein -DNA cross-links and DNA strands breaks, G 2 -phase arrest and chromosome endoreduplication are some of the prominent effects of hoechst-33342 treatment, [31] cel lular effects are reminiscent of those induced by topoisomerase poisons and other DNA damaging agents. [32] Since tumor cells show elevated levels of topoisomerases, the ligand has been suggested to be a potential anticancer drug. [33] Studies in murine and human tumor cell lines have indeed shown that the ligand enhances the ionizing radiation and UV induced cytotoxicity by inhibiting DNA repair, leading to enhanced cytogenetic damage and apoptosis. [30, 34, 35, 36] In vivo studies with focally irradiated Ehrlich ascites tumors in mice have clearly shown a dose dependent radiosensitization by the ligand resulting in local tumor control and cure rates of nearly 50%. [37] Since tumor cells differ in their topoisomerase pool size as well as in the de gree of chromatin condensation, the radiomodifying effects of hoechst can vary among different tumors. Therefore, in the present studies we investigated the radiomodifying effects of hoecsht-33342 in human tumor cell lines of differ ent origin and biological behaviour. Our results in two glioma (BMG-1, U-87) and two squamous carcinoma (4451, 4197) cell lines show that the radiosensitizing effects of hoechst 33342 are heterogeneous and independent of p53 status.
MATERIALS AND METHODS

Cell Line
The cerebral glioma cell line (BMG-1; diploid,wild type p53) was established in Bangalore, India.
[ [39] of Med. Rad. Bio. Essen. Cells were maintained on Dulbecco's Modified Eagles Medium (DMEM) supplemented with 5% fetal bo vine serum for BMG-1, 10% for 4451 and U-87 and 20% for 4197, HEPES buffer (10 mM) and antibiotics (Penicillin G 50000 unit/l. Streptomycin 38850 unit/l and Nystatin 9078 unit/l). Stock culture were maintained in the exponential growth phase by passaging them every 3 days with their respective growth medium in 25 Cm 2 plastic flask (Tarson, Calcutta, India).
Chemicals
Hoechst 33342, Dulbecco,s Minimum Essential Medium (DMEM) and all antibiotics, citric acid and tween-20, the fetal calf serum were procured from Sigma Chemical Co. (St Louis, USA). The immuno-flowcytometric reagents, primary antibody (anti cyclin B1, anti-p53) were procured from Becton Dickinson (San Jose, USA) and secondary antibody (IgG 1 whole molecule with FITC conjugate) was also procured from Sigma. Phosphate buffered saline (PBS) and Hanks Balanced Salt Solution (HBSS) was obtained from Hi-Media (Mumbai, India).
Experimental Procedure and Irradiation
Before treatment, the growth medium was replaced with HBSS containing 5mM glucose, which does not support growth. Hoechst was added 1h prior to irradiation in the dark, and irradiated at room temperature with a co -60 source (ELDORADO-78, USA) teletherapy unit (dose rate = 1.2 Gy/ min). Following treatments, hoechst was removed and cells were washed with HBSS. Respective growth media were supplemented to each flask and cells were grown for vari ous time intervals to study the radiobiological parameters like micronuclei formation, apoptosis, clonogenic survival etc.
Clonogenic Cell Survival Assay 150-1500 Cells were plated (depending on the treatment) in 60-mm petri dishes 12-15 hr prior to treatment, to facili tate the attachment of cells. After various treatments, petri dishes were incubated at 37 0 C in a humidified 5% CO at 2 mosphere for 8-10 days. Colonies were fixed in methanol and stained with 1-% crystal violet (made in 70% metha nol). Colonies containing more than 50 cells were counted. Differences between the mean values of data from differ ent groups were tested for statistical significance by stu dent's t test. The modifying factor r hoechst was calculated as shown below:
Cell Proliferation
Exponentially growing cells were plated at a density of 6000 to 8000 cell/cm 2 . 20-24h later growth media replaced and HBSS was added to each dish containing hoechst at iso survival concentration for 1hr. Following irradiation the HBSS was immediately replaced, and respective growth media were added. The cells were harvested every 24 h, using 0.05% trypsin, counted using hemocytometer, and fixed in 70%-chilled ethanol for the analysis of cell cycle distribu tion by flow cytometry. Cell proliferation was calculated by: P = N t /N 0 Where N = number of cells after time t. 
Radiation-induced Division Delay
Ethanol-fixed cells were washed twice with PBS (Ca 2+ and Mg 2+ free) and treat with RNAse (200 mg/ml final conc) for 30min at 37 0 C. Wash the cell again with PBS and stained with propidium Iodide (final conc. of 50 um/ml). Measure ments were made by Laser based Flow-cytometer (FACS Callibur, Becton Dickenson, San Jose, USA) using cell quest soft ware in list mode. Cell cycle analysis was carried out by using MOD FIT LT-2 software variety (SanJose, USA).
Micronuclei Analysis
Air-dried slides of acetic methanol fixed cell were stained with DNA specific fluorochrome, diamidino-2-phenylindole dihydrochloride, DAPI. [30] Approximately 3000 cells were analyzed from duplicate slides. Since radiation as well as hoechst are known to alter the rate of cell proliferation which influences the expression of micronuclei, cell num bers as well as percentage of cells with micronuclei were determined as a function of time up to 2-3 population dou bling after irradiation. Data were analyzed by obtaining integrated values of micronuclei frequency and normaliz ing the values with respect to cell numbers as describe ear lier. [38] The frequency of cells with micronuclei called the M fraction (MF) was calculated as: MF (%) = N m /N t x 100, where N is the number of cells with micronuclei and N is the m t total number of cells analyzed. A modifying factor ρ
MF Hoechst
was calculated as shown below, to evaluate the radiomodifying effects by taking in to account the effects on cell proliferation:
A ρ value >1 means an increase in the radiation damage due to the modifier, while ρ < 1 means a decrease in the damage.
Apoptosis
Morphologically, marked condensation and margination of chromatin, fragmentation of nuclei and cell shrinkage char acterize apoptotic cells and a good correlation between these morphological changes and DNA ladder (one of the hallmarks of cells undergoing apoptosis) has been demon strated [41] . Percentage of cells undergoing apoptosis was determined microscopically using DAPI as a DNA specific flurochrome for cells staining. At least 1000 cells were counted and percent apoptotic cells determined from slides prepared for micronuclei formation. The modifying factor ρ Apo was calculated similar to micronuclei to evaluate Hoechst the radiomodifying effects of hoechst.
Cyclin B1
Immunostaining was performed as described earlier [40] . Briefly, Ethanol fixed cells was first permeabilized with 0.25% Triton-X 100 in PBS for 5 min on ice. Cells were then washed with PBS and incubated with respective primary antibodies diluted (1:400) in PBS containing 1% BSA, (Pharmingen, a Becton Dickinson Co.) for overnight at 4°C. Cells were then washed with PBS containing 1% BSA and incubated with FITC labeled goat anti-mouse IgG 1 second ary antibody (Sigma chemicals) diluted 1:100 in PBS contain ing 1% BSA for 30 min at 4°C. After washing, cells were treated with 0.1% RNase and propidium iodide (PI, 10mg/ ml) for 30 min. Green (FITC) and red (PI) fluorescence were recorded for at least 10,000 events as described earlier. Cell cycle was also analyzed from the measurement of DNA con tent from PI fluorescence.
RESULTS
Cell survival
The clonogenic potential (plating efficiency) was nearly 70% in all the cell lines investigated. hoechst-33342 is known to be cytotoxic due to its inhibitory effects on topoisomerases I and II [42, 43] , the vital nuclear enzymes, whose levels could differ among different cell lines. Therefore, we first investi gated the cytotoxicity of hoechst in these four cell lines. The dose response for hoechst-33342 clearly showed that 4197 cells were highly sensitive among the four cell lines investigated, with an IC 50 (concentration producing 50% cell death) value of 0.25 µM followed by 4451 (IC 50 = 4.5 µM), where as both the glioma cell lines were relatively less sen sitive with an IC 50 value of 10 mM [ Figure 1 & Table 1 ]. These variations in the sensitivity correlated reasonably well with the TOP I levels analyzed by the plasmid relaxation assay (Shailja et al., unpublished observations). Addition of hoechst 1 h before irradiation enhanced the radiation dose response of BMG-1 cells and nearly abolished the shoulder (data not shown) as reported earlier in human cells. [44, 45, 46] The de gree of radiosensitization was dependent both on the con- 
Cell proliferation
Since DNA damage induce cell cycle checkpoints resulting in G 2 block as well as G 1 -S transition delay, and both ioniz ing radiation and hoechst are known to inhibit cell prolif eration we examined the growth inhibitory effects and cell cycle distribution at various time intervals after the treat ments. An absorbed dose of 2Gy induced a marginal delay in the growth followed by recovery in all the cells, although the extent of delay was somewhat different among these cell lines [ Figure 2 ]. While hoechst had a profound effect on the growth of unirradiated as well as irradiated BMG-1 cells, a moderate effects was seen in U87 and 4451 cells, with minimal effect in 4197 [ Figure 2 ]. Flowcytometric analysis of the cell cycle distribution carried out at 24 h after treat ment showed that radiation as well as hoechst independ ently induced G 2 block in all the cell lines, albeit to different extents [ Figure 3 ]. However, the combination did not result in a higher level of G 2 block in these cell lines, except in BMG-1. Measurements made at subsequent intervals up to 72 h post-treatment, suggested that under these conditions (IR dose and hoechst concentrations) the G 2 block was es sentially transient, as the cell cycle distributions returned to the levels in untreated cells (data not shown).
Cytogenetic Damage
Mitotic death (linked to cytogenetic damage) and the inter phase death (mainly in the form of apoptosis) are two im portant modes of cell death following irradiation. There fore, we investigated the contribution of mitotic death in well as over all induction until 72 h were analyzed. The fre quency of un-irradiated cells with micronuclei (M-fraction) was in the range of 1-4%. The kinetics of micronuclei in duction following an absorbed dose of 2 Gy showed a maxi mum frequency in the range of 10-15% among these cell lines, which peaked between 20 and 48 h post-irradiation [ Figure 4 ]. This was followed by a decline in the MF values, due to the well-known dilution effects. [37] Under these con ditions, exposure of cells to hoechst for 1 h at IC 50 concen trations induced a maximum micronuclei frequency in the range of 5-9% in these cells [ Figure 4 ]. Under the present experimental conditions, hoechst (1 h at IC 50 concentrations) significantly enhanced the radiation induced micronuclei formation in U-87, BMG-1 and 4197 cells [ Figure 4 ]. The p MN values calculated at 48h post treatment were 1.54, 2.10 and 1.53 respectively. However, no significant increase was ob served in 4451 cells. These results suggest that increase in the cytogenetic damage is a significant contributing factor for the enhanced radiation induced cell death by hoechst 33342 in three of the four cell lines investigated (U-87, BMG 1 and 4197).
Apoptosis
Induction of apoptosis was studied by the morphological analysis of cells stained with a DNA specific fluorescent dye (DAPI)) as described earlier. [30] Under the present experimen tal conditions a significant induction of apoptosis was ob served only after 72h following irradiation (delayed apoptosis) similar to earlier observations. [30] While an en hancement in the radiation induced apoptosis was observed in hoechst-33342 treated BMG-1 cells no significant changes were observed in U-87, 4451 and 4197 cell lines. However, in U87 cells a significant induction was evident with hoechst alone (6%; Figure 5 ) under these conditions (1 h at IC 50 con centrations), while the increase of radiation-induced apoptosis was insignificant. Interestingly, a significant in duction of apoptosis could not be observed either with hoechst or gamma rays (2 Gy) alone or in combination in both the squamous carcinoma cell lines viz. 4451 and 4197 ( Figure 5 ).
Cyclin B1
Varying fractions of DNA damage carrying cells arrested in G 2 as well as G 1 phases have often been shown to undergo apoptosis. The induction of apoptosis particularly in G 2 +M cells has been shown to be cyclin B1 mediated and p53 sta tus dependent. [47] Results presented here [ Figure 3 ] did show induction of G 2 block as well as delayed apoptosis in some of the cell lines. Therefore, we examined the levels of en dogenous as well as treatment-induced levels of cyclin B1 and p53 in these cells. Interestingly enough, both the glioma cell lines showed relatively higher endogenous levels of cyclin B1 as compared to the two squamous carcinoma cell lines [ Figure 6 ]. In addition, treatment induced cyclin B1 levels were also clearly elevated in both the glioma cell lines, while significant changes were not noted in the two squa mous carcinoma cells. In this respect, hoechst-33342 ap peared to induce a relatively higher level of cyclin B1 as compared to radiation, with no further significant increase by the combination [ Figure 6 ]. Therefore, it appeared that cyclin B1 could be partly responsible for the induction of apoptosis observed in the two-glioma cells. However, this induction of apoptosis did not seem to be strongly corre lated with the p53 status as BMG-1, U-87 and 4197 cells carry a wild type p53 gene, while 4451 cells are mutated. [39, 48] We also examined the p53 levels following the treatment and found no significant induction in any of the cell lines (data not shown).
DISCUSSION
Ionizing radiation elicits a number of cellular and molecu lar responses such as induction and repair of DNA damage, cell cycle disturbances, programmed cell death, alterations in gene expression and signal transduction path ways. [8, 11, 49, 50, 51] Induction and repair of DNA damage are cen tral among the several molecular targets for modifying cel lular radiation responses and most often correlated well with cell death. [52, 53] DNA topoisomerases, which break and rejoin DNA in a concerted fashion thereby reliving the ten sion, have been recognized to play a major role in many DNA transactions, including DNA repair.
[54] Several classes of compounds, which promote chromatin condensation in interphase cells, are known to modify the radiosensitivity. [55] Radiosensitization has been observed in many instances by modifiers of phosphatases, histone deacetylases, and totoisomerase inhibitors. [56, 57, 58] Although the radiosensitizing effects of the ligand has been presented here for the therapeutically relevant dose of 2 Gy, preliminary studies had shown that the ligand pro foundly reduces the "shoulder" of the survival curve, while altering minimally the cell death at higher doses (> 5 Gy). These observations are similar to the results reported ear lier with this ligand and camptothecin, a widely known TOP1 poison [45] in human cells. [33] TOP 1 has been reported to be the primary target responsible for the cytotoxicity induced by DNA minor groove-binding drugs including hoechst 33342. [33, 59] The magnitudes of "shoulder" in the radiation dose response curve for cell survival is a measure of the repair capacity for "sublethal damage" [60, 61] and therefore, the sensitization by the ligand could be partly due to the inhibition of the repair of sub-lethal damage. Alternatively, the ligand may saturate cellular repair processes responsi ble for the repair of sublethal DNA damage caused by ion izing radiation. [46] The ligand is known to stabilize the TOP1-DNA cleavable complexes in actively DNA sentisizing cells, [62] resulting in the formation of DNA damage as has been found in case of the TOP1 poison camptothecin. [62, 63] However, the radiosensitization by Hoechst-33342 differed somewhat from other TOP 1 inhibitors such as camptothecin with ref erence to the schedule dependency. While addition of camptothecin immediately following irradiation has been shown not to sensitize Chinese hamster DC3F cells, [45] sig nificant sensitization has been reported with hoechst-33342 in EAT and BMG-1 cells under these conditions. [30] The precise molecular mechanism of radiosensitization of DNA topoisomerase I-targeting drugs still remains to be defined. It is possible that radiosensitization is brought about by the interaction of cleavable complexes stabilized by topoisomerase I inhibitors and a variety of primary DNA lesions induced by radiation. It has been suggested that the interaction of "potentially sublethal" cleavable com plexes with cellular processes such as DNA replication, RNA transcription, and DNA repair may transform them into "sub lethal" DNA damage, which upon interaction with radia tion-induced DNA damage gets converted into "lethal" DNA damage. [33, 64] In this perspective, it is pertinent to note that the ligand has been shown to alter the degree of chroma tin condensation [28] and inhibit transcription and replica tion in a concentration dependent manner. [65] These obser vations suggest that the bound ligand can hinder the re pair of radiation-induced DNA damage and also alter the expression of genes related to the damage response path ways resulting in enhanced cell death. [66, 67] Lack of a strong correlation between the cytotoxic effects of the ligand (characterized by the IC 50 values) and its radiosensitization (ρ vales in table:1) among the four cell lines investigated here suggests that TOP1 inhibition is not solely responsible for the radiosensitizing effects. For ex ample, the IC 50 value of U-87 cells (10 mM) was 40 times higher than that of 4197 cells (0.25 mM), while their r val-ues were nearly identical (3.50 & 3.85) . Similarly, BMG-1 and U-87 cells with identical values of IC differed in their 50 ρvalues by two folds [ Table 2 ].
Loss of clonogenic survival generally reflects anti-prolifera tive effects, including induction of apoptotic and nonapoptotic forms of cell death. The apparent quantita tive differences in the effects of Hoechst on radiation-in duced growth inhibition ( Figure 2 ) and loss of clonogenicity [ Table 1 ] could be related to the cell density dependent dif ferences in the cellular responses, as the proliferation stud ies employed a higher cell density (~ 12,000 -15,000 cells per cm
2
) as compared to a density of (12 -96 cells per cm 2 ). Mitotic death is primarily responsible for the loss of clonogenicity in most of the epithelial tumors, often lead ing to delayed apoptosis as a secondary event.
[68] On the other hand, apoptosis contributes significantly to the ra diosensitivity of hematopoietic cells, where radiation in duces both intrinsic as well as extrinsic pathways of cell death.
[69] Induction of apoptosis has been considered as a potential mechanism for radiosensitization, although its role in therapeutic gain has been questioned recently.
[70] The present results suggest that the radiosensitization by hoechst-33342 was partly due to an increase in the cytoge netic damage linked mitotic death ( Figure 4 and Table 1) , with a small increase in delayed apoptosis only in the two glioma cell lines. Differences in the enhancement of cell death (ρ SF ) and micronuclei formation (ρ MF ) suggest that other factors such as enhancement of genomic instability may also contribute to the radiosensitization.
Genomic instability can manifest several generations after exposure to many DNA-damaging agents, including ioniz ing radiation [71, 72, 73] and cause delayed non-apoptotic form of reproductive death in surviving cells. [74] Although the nature of the primary lesion(s) and the mechanism of this delayed chromosomal instability induced by radiation re main largely unknown, it has been speculated that some of the radiation-induced DNA lesions may trigger cellular proc esses, including gene deletions, eventually leading to de layed chromosomal instability. [71, 72, 73] A careful examination of the IC 50 values and the MF values as well as delayed apoptosis (observed at 72 h after treatment) suggests that lesions induced by the ligand (mainly cleavable complexes)
are not only capable of inducing genomic instability-linked non-apoptotic death, but are also capable of enhancing this effect, which may partly account for the synergistic cell kill observed in some (BMG-1 & U-87), but not in all cells.
Hoechst-33342 has been shown to induce apoptosis by it self involving a number of metabolic perturbations, which appears to be mitochondria dependent, but p53 independ ent, [75] as observed in the present studies for the induction of apoptosis by hoechst as well as the combined treatment. Some of these perturbations include inhibition of TOP1 and interference in TATA binding protein leading to the stalling of RNA pol II involved RNA synthesis. [76] Interaction of le sions induced by hoechst-33342 and radiation resulting in the formation of complex irreparable damage may accen tuate these processes resulting in enhanced apoptosis. Since the levels and activities of topoisomerases as well as repair capacities of cells differ considerably among different tumor cell lines, the induction of apoptosis may vary as observed in the present studies between the two glioma (BMG-1 & U-87) and squamous carcinoma (4451 & 4197) cell lines. Fur ther, the induction of apoptosis has also been shown to be cyclin B1 mediated under certain conditions.
[47] Therefore, differences in the endogenous as well as treatment-induced cyclin B1 levels may also be responsible for variations in the extent of apoptosis induction. The levels of bax and bcl-2 are important determinants of mitochondria depend ent apoptosis, with the bax/bcl-2 ratio determining the re lease of Cytochrome c that activates caspases.
[69] Prelimi nary observations show that the bax/bcl-2 ratios of 8-10 found in both the glioma cell lines (BMG-1 & U-87) were nearly two folds higher than the ratio (4-5) observed in the squamous carcinoma lines 4451 & 4197 (data not shown).
Both ionizing radiation and hoechst-33342 induced cyto toxicity show cell cycle specificity. While G 2 and M phase cells are more sensitive to ionizing radiation, [77, 78, 79] S-phase cells to a very great extent as well as G 2 and M phase cells are sensitive to hoechst. [80] Therefore, heterogeneity in the responses among the cell lines could partly arise on account of differences in the cell cycle distribution at the time of treatment. However, in the present studies, the cell cycle distribution of the four cell lines at the time of treatment were essentially similar (data not shown) and may not be Both hoechst-33258 and hoecsht-33342 are well known scav engers of free radicals [23, 81] and also suggested to quench long-lived DNA radicals, [82] thereby reducing the induction of DNA damage in solution [23, 83] and in cells under certain conditions. [29, 30] This suggests that hoehcst-33342 would pro tect cells against radiation-induced cytotoxicity, since DNA damage is primarily responsible for the cell death.
[5] Indeed, reduced cytogenetic damage and enhanced animal survival have been reported in whole body irradiated mice when hoechst is administered before irradiation. [84] However, the ligand appears to be relatively inefficient in reducing the radiation-induced damage to the nucleotides under anoxic conditions, [82] suggesting that the ligand may not signifi cantly reduce the damage induction due to variable oxy gen tension among different cells and particularly the hy poxic cells in the tumor. On the other hand, inhibition of topoisomerases as well as chromatin structure dependent DNA repair would result in a higher level of residual DNA damage resulting in a higher level of cytogenetic damage, cell cycle perturbations, delayed apoptosis and genomic instability, thereby enhancing the cytotoxicity, as observed in the present studies (Figures 1-6 ). Furthermore, interac tions between radiation-induced DNA damage and lesions formed due to toposiomerase inhibition by the ligand would also enhance the cytotoxicity. Since tumor cells and tissues are often associated with reduced oxygen tension and el evated levels of topoisomerases, hoechst has a higher prob ability of inducing radiosensitization in tumor cells and tis sues, although it has the potential to reduce the induction of DNA damage to a certain extent. Indeed, while a dose dependent radiosensitization has been observed in focally irradiated Ehrlich ascites tumors, [37] a significant protection in the form of enhanced survival and reduced bone marrow damage has been reported following whole body irradia tion of the mice. [84] In this respect, therefore the ligand ap pears to be a promising radiosensitizer for application. How ever, issues related to the toxicity to the normal cells, par ticularly the proliferating bone marrow and other tissues in the form of mutagenic, teratogenic and clastogenic ef fects will have to be addressed before contemplating clini cal studies. In this direction, we have recently shown that certain hoechst analogues like the dimethoxy analogue (DMA) and Trisbenzimidazole (TBZ) derivatives of hoechst 33258 are quite promising as radioprotectors and are not associated with the toxic effects seen with hoechst. [85, 86] However, the challenge will be to develop such ligands that exploit differences in the finer organization of the genome between tumor and normal cells, thereby affording differ ential radiomodification.
